EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1. | Registration Statement (Form S-8 No. 333-255061) pertaining to the Gain Therapeutics, Inc. 2020 Omnibus Incentive Plan, |
2. | Registration Statement (Form S-8 No. 333-266142) pertaining to the Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan and the Gain Therapeutics, Inc. 2022 Equity Incentive Plan, |
3. | Registration Statement (Form S-8 No. 333-272255) pertaining to the Gain Therapeutics, Inc. 2022 Equity Incentive Plan, |
4. | Registration Statement (Form S-3 No. 333-265061) of Gain Therapeutics, Inc., and |
5. | Registration Statement (Form S-1 No. 333-276145) of Gain Therapeutics, Inc.; |
of our report dated March 26, 2024, with respect to the consolidated financial statements of Gain Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2023.
/s/ Ernst & Young AG
Lugano, Switzerland
March 26, 2024